Sidonia Santos
Instituto Português de Oncologia Francisco Gentil
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sidonia Santos.
Ecancermedicalscience | 2018
Ana Catarina Freitas; Ana Opinião; Sofia Fragoso; Hugo Nunes; Madalena Santos; Ana Clara; ra Bento; Ana Luis; Jorge Silva; Cecília Moura; Bruno Felipe; Patricia Machado; Sidonia Santos; Saudade André; Paula Rodrigues; Joana Parreira; Fátima Vaz
Background Hereditary breast and ovary cancer syndrome affects both genders but little is known about the uptake of genetic services by men. The objective of this study is to characterise the male population counselled through a multidisciplinary breast/ovarian program. Methods Descriptive analysis of male patients counselled from January 2000 to December 2015. Data in this analysis include new cancer diagnoses during prospective follow up. Results From 4,320 families registered, 362 male patients were identified: 236 (65.2%) from hereditary cancer families (HCF) and 126 (34.8%) from non-HCF. In HCF, 121 patients (51.3%) were mutation carriers (MC): BRCA2 – 102 (84.3%), BRCA1 – 16 (13.2%), CHEK2 – 1 (0.8%) and TP53 – 2 (1.7%). Non-HCF included 126 patients: 85 (67.5%) belonged to families without pathogenic mutations or with variants of unknown clinical significance; 22 (17.5%) refused testing after counselling and 19 (15.0%) did not meet criteria for testing. Both HCF and non-HCF included patients with previous cancer diagnoses: HCF- Breast Cancer (BC) - 18; prostate cancer (PC) - 13; melanoma - 1; others - 7) and non-HCF (BC - 77; PC - 20; gastric cancer (GC) - 1; melanoma - 8; bladder cancer - 1; others - 22). From the 121 MC identified (including the TP53 and CHEK2 carriers), 97 patients (80.2%) adhered to prospective surveillance. With a median follow-up of 36.9 months, 17 cancers were diagnosed in 14 patients, PC being the most frequently diagnosed neoplasia (5 cases). Eleven patients (78.6%) are alive and three patients died of advanced cancer (2 with GC, 1 with disseminated adenocarcinoma). Conclusion We observed a high adherence to counselling, genetic testing and active surveillance by men belonging to hereditary BC families. Male carriers of pathogenic DNA variants are at risk for several cancers and should be included in prospective follow-up studies.
Breast Cancer Research and Treatment | 2009
Ana Rita Marques; Elsa Teixeira; Joana Diamond; Helena Correia; Sidonia Santos; Lara Neto; Manuel Ribeiro; Ana Miranda; José Luís Passos-Coelho
Journal of Clinical Oncology | 2018
Maria Beatriz Mira; I Miguel; Sofia Fragoso; Ana Luis; Ana Clara; Sandra Bento; Ana Opinião; Patricia Machado; Sidonia Santos; Paula Rodrigues; Joana Parreira; Ana Francisca; Fátima Vaz
Annals of Oncology | 2018
D H R Machado; Sofia Fragoso; Ana Opinião; Ana Clara; S. Bento; A C Luís; I Miguel; Sidonia Santos; Patricia Machado; Paula Rodrigues; Joana Parreira; Fátima Vaz
Annals of Oncology | 2018
M B D O Mira; I Miguel; Sofia Fragoso; Ana Opinião; A C Luís; Ana Clara; S. Bento; Patricia Machado; Sidonia Santos; Paula Rodrigues; Joana Parreira; Fátima Vaz
Journal of Clinical Oncology | 2017
Hugo Nunes; Patricia Machado; Sofia Fragoso; Sidonia Santos; Fernanda Silva; Ana Félix; Ana Luis; Ana Opinião; Ana Clara; Sandra Bento; Ana Miranda; Ana Francisca; Fátima Vaz
Annals of Oncology | 2017
R. Vitorino; Fátima Vaz; A.L. Carvalho; S. Bento; Ana Luis; Ana Opinião; Ana Clara; J. Dupont; Sidonia Santos; Patricia Machado; Sofia Fragoso; Paula Rodrigues; Joana Parreira; C. Moura
Journal of Clinical Oncology | 2016
Ana Catarina Freitas; Ana Opinião; Hugo Nunes; Ana Clara; Sandra Bento; Ana Luis; Jorge Silva; Cecília Moura; Bruno Filipe; Sofia Fragoso; Patricia Machado; Sidonia Santos; Paula Rodrigues; Joana Parreira; Fátima Vaz
Journal of Science and Medicine in Sport | 2014
Jaciane Mota; Sidonia Santos; Susana Vale
Journal of Science and Medicine in Sport | 2012
Jaciane Mota; Luisa Soares-Miranda; J. Maia e Silva; Sidonia Santos; Susana Vale